Living Labs: PFAS use in medical applications – exploring transition scenarios

| March 28th, 2025 | News

How can we find the right balance between maintaining high-quality healthcare and reducing PFAS pollution? That was the central question explored by a diverse group of experts from hospitals, healthcare product manufacturers, plastics producers, government bodies, NGOs, and research institutes, during a 2-day Living Lab workshop as part of the SOS-ZEROPOL2030 project.

There is growing societal pressure to move away from the use of PFAS, even though these materials play a crucial role in medical applications, such as clothing, catheters, implants and anaesthetic gases. Finding alternatives, however, is a complex challenge.

Exploring Scenarios for PFAS Reduction in the Medical Sector

The Living Lab ‘Exploring Scenarios for PFAS Reduction in the Medical Sector´ was held from 25-26 March, in Utrecht, The Netherlands. It brought together 20 experts from various European countries and built on the findings of a previous Living Lab held in April 2024, which identified challenges and opportunities for reducing PFAS throughout the lifecycle of medical applications—from production to end-of-life.

Wouter-Jan Strietman, from Wageningen Social & Economic Research and regional lead for the North-East Atlantic region: “Through interactive group discussions, and valuable input by the experts, we were able to explore the complex and often multi-faceted challenges and trade-offs involved in managing and governing PFAS to reduce their use in medical applications.”

Scenarios to reduce use of PFAS across production chain

The discussions centred on scenarios to reduce the use of PFAS in the production chain of medical applications – from the production of the basic raw material to end-of-life. For each scenario, the experts focused on tackling challenges in management and governance, as well as exploring trade-offs and opportunities to minimise the use and emissions of PFAS within these product chains.

The resulting conclusions were both specific to the medical sector and also provided broader insights applicable to other industries where similar challenges arise across the product chain. The lessons learned from this session will be summarised in a report and help shape the Source to Seas- Zero Pollution 2030 project’s recommendations and guidance to the European Commission in support of ending pollution in European seas by 2030.

About Living Labs

SOS-ZEROPOL2030 focuses on four priority pollutants: nutrient inputs, contaminants, plastic litter, and underwater noise, alongside two case study pollutants: per- and polyfluoroalkyl substances (PFAS) and tyre wear particles (TWPs). It addresses these issues across three European Regional Seas: the Black Sea, the Mediterranean Sea, and the North-East Atlantic.

The first round of our Living Lab workshops, focusing on PFAS for the North-East Atlantic and the Black Sea and TWPs for the Mediterranean, was held in 2024 in the Netherlands, Bulgaria, and Greece respectively.

Read more on the issue of PFAS in the SOS-ZEROPOL 2030 StoryMap here and have a look at some of our project resources, such as reports, factsheets, and infographics under our Resources tab.

News

Editorial third annual newsletter

Dear reader, Welcome to the third year of the SOS-ZEROPOL2030 project, and the third newsletter! Over the past year, SOS-ZEROPOL2030 has made significant strides in its mission to develop a holistic p[...] Read more
From Source to Sea: Exploring an integrated approach to marine pollution at the MARE People & the Sea Conference

The MARE People & the Sea Conference XIII held at the University of Amsterdam (The Netherlands) from 23 to 27 June 2025, brought together (social) scientists from around the world to delve into th[...] Read more
Living Labs Across European Seas: SOS-ZEROPOL2030 Empowers Stakeholders to Tackle Marine Pollution

The Source to Seas – Zero Pollution 2030 (SOS-ZEROPOL2030) project has successfully completed two rounds of Living Labs (LLs)—held in 2024 and 2025—as part of its ambitious effort to co-develop [...] Read more